2020. a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis. International Journal of Pharmacetical Sciences Letters. 10, 1 (Jan. 2020), 29–39.